Incremental and independent value of cardiopulmonary exercise test measures and the Seattle Heart Failure Model for prediction of risk in patients with.

Slides:

Advertisements

Similar presentations

Comparative cost-effectiveness of the HeartWare versus HeartMate II left ventricular assist devices used in the United Kingdom National Health Service.

Advertisements

Systolic blood pressure on discharge after left ventricular assist device insertion is associated with subsequent stroke Michael E. Nassif, MD, Anjan Tibrewala,

Sixth INTERMACS annual report: A 10,000-patient database James K. Kirklin, MD, David C. Naftel, PhD, Francis D. Pagani, MD, PhD, Robert L. Kormos, MD,

Cost-Effectiveness of Sensor-Augmented Pump Therapy in Adults with Type 1 Diabetes in the United States Shital Kamble, PhD, Kevin A. Schulman, MD, Shelby.

Janet T. Lee, MD, Rosemary F. Kelly, MD, Marshall I

Predictors of survival in restrictive chronic lung allograft dysfunction after lung transplantation Stijn E. Verleden, PhD, David Ruttens, MD, Elly Vandermeulen,

CYFRA 21-1 as a Prognostic and Predictive Marker in Advanced Non–Small-Cell Lung Cancer in a Prospective Trial: CALGB Martin J. Edelman, MD, Lydia.

CHA2DS2-VASC and CHADS2 Scores Predict Adverse Clinical Events in Patients With Pacemakers and Sinus Node Dysfunction Independent of Atrial Fibrillation

The utility of 6-minute walk distance in predicting waitlist mortality for lung transplant candidates Anthony Castleberry, MD, MMCI, Michael S. Mulvihill,

Patterns and Predictors of Physical Functional Disability at 5 to 10 Years After Heart Transplantation Kathleen L. Grady, PhD, RN, David C. Naftel, PhD,

Utility of the Seattle Heart Failure Model in patients with cardiac resynchronization therapy and implantable cardioverter defibrillator referred for.

Impact of aortic valve closure on adverse events and outcomes with the HeartWare ventricular assist device David Dobarro, MD, Marian Urban, MD, Karen.

James K. Kirklin, MD, Francis D. Pagani, MD, PhD, Robert L

Can the Seattle Heart Failure Model Be Used to Risk-stratify Heart Failure Patients for Potential Left Ventricular Assist Device Therapy? Wayne C. Levy,

Impact of initial Norwood shunt type on young hypoplastic left heart syndrome patients listed for heart transplant: A multi-institutional study Waldemar.

Primary Signet-Ring Carcinoma (SRC) of the Lung: A Population-Based Epidemiologic Study of 262 Cases with Comparison to Adenocarcinoma of the Lung Sai-Hong.

Influence of diabetes on survival in patients with cystic fibrosis before and after lung transplantation Don Hayes, MD, MS, Alpa V. Patel, MD, Sylvester.

Limitations of right heart catheterization in the diagnosis and risk stratification of patients with pulmonary hypertension related to left heart disease:

Pre-operative mortality risk assessment in patients with continuous-flow left ventricular assist devices: Application of the HeartMate II risk score

Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease Joseph P. Archie, PhD, MD Journal of Vascular.

Volume 107, Issue 5, Pages (May 1995)

Outcomes in highly sensitized pediatric heart transplant patients using current management strategies Alfred Asante-Korang, MD, Ernest K. Amankwah, PhD,

Susanna L. Matsen, MD, Bruce A. Perler, MD, MBA, David C

Volume 5, Issue 4, Pages (April 2006)

Min-Woong Sohn, PhD, Judith L. Meadows, MD, Elissa H

The Value of a Symptom Cluster of Fatigue, Dyspnea, and Cough in Predicting Clinical Outcomes in Lung Cancer Survivors Andrea L. Cheville, MD, MSCE,

Does the survival advantage of nonwhite dialysis patients persist after case mix adjustment?∗ ∗2 Douglas E Mesler, MD, MPH, Ellen P McCarthy, PhD, Susan.

John R. Meuleman, MD, William F. Brechue, PhD, Paul S

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD

Prognostic Value of Primary Tumor Volume Changes on kV-CBCT during Definitive Chemoradiotherapy for Stage III Non–Small Cell Lung Cancer Patrick Wald,

The effect of center volume on the incidence of postoperative complications and their impact on survival after lung transplantation Arman Kilic, MD,

Susan C. Scott, MD, Nathan A. Pennell, MD, PhD

Patterns of Care and Treatment Outcomes of Elderly Patients with Stage I Esophageal Cancer: Analysis of the National Cancer Data Base Amy C. Moreno,

Long-term survival and stroke-free survival after eversion carotid endarterectomy for asymptomatic severe carotid stenosis Enzo Ballotta, MD, Giorgio.

Patient and Graft Survival Following Kidney Transplantation in Recipients With Cystinosis: A Cohort Study Rebecca A. Spicer, MBChB, Philip A. Clayton,

Influence of Pulmonary Hypertension on Patients With Idiopathic Pulmonary Fibrosis Awaiting Lung Transplantation Don Hayes, MD, MS, Sylvester M. Black,

Outcomes of surgery for young children with multivessel pulmonary vein stenosis Luis G. Quinonez, MD, Kimberlee Gauvreau, PhD, Michele Borisuk, NP, Christina.

Less Is More in Post Pediatric Heart Transplant Care

Influence of diabetes on survival in patients with cystic fibrosis before and after lung transplantation Don Hayes, MD, MS, Alpa V. Patel, MD, Sylvester.

Distance covered during a six-minute walk test predicts long-term cardiovascular mortality and hospitalisation rates in men with systolic heart failure:

Pretreatment Anemia Portends Poor Survival and Nonlocal Disease Progression in Patients with Stage I Non–Small Cell Lung Cancer Treated with Stereotactic.

Endovascular abdominal aortic aneurysm repair: Long-term outcome measures in patients at high-risk for open surgery Gregorio A. Sicard, MD, Robert M.

Todd C. Crawford, MD, J. Trent Magruder, MD, Joshua C

Impact of Positive Nodal Metastases in Patients with Thymic Carcinoma and Thymic Neuroendocrine Tumors Benny Weksler, MD, Anthony Holden, MD, Jennifer.

Effects of Chemotherapy on Survival of Elderly Patients with Small-Cell Lung Cancer: Analysis of the SEER-Medicare Database Laura C. Caprario, MD, MS,

Volume 7, Issue 11, (November 2010)

Does Granulocyte Colony–Stimulating Factor Affect Survival in Patients with Advanced Non-small Cell Lung Cancer? Goulnar Kasymjanova, MD, Harvey Kreisman,

Defining high risk in endovascular aneurysm repair

National trends in utilization, mortality, and survival after repair of type B aortic dissection in the Medicare population Douglas W. Jones, MD, Philip.

Is the B12/CRP Index More Accurate Than You at Predicting Life Expectancy in Advanced Cancer Patients? Filipa Tavares, MD Journal of Pain and Symptom.

Durability of left ventricular assist devices: Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) 2006 to 2011 William L.

Should Patient-Rated Performance Status Affect Treatment Decisions in Advanced Lung Cancer? Esther Dajczman, RN, MScA, Goulnar Kasymjanova, MD, PhD,

Elevated High-Density Lipoprotein Cholesterol Is Associated with Hyponatremia in Hypertensive Patients Ariel Israel, MD, PhD, Ehud Grossman, MD The.

Heterogeneity of Lung Volume Reduction Surgery Outcomes in Patients Selected by Use of Evidence-Based Criteria Matthew R. Lammi, MD, Nathaniel Marchetti,

It’s All in the “Swerve of the Curve”

Pretransplant Panel Reactive Antibodies in Human Lung Transplantation: An Analysis of Over 10,000 Patients Ashish S. Shah, MD, Lois Nwakanma, MD, Christopher.

Visceral Pleural Invasion Is Not Predictive of Survival in Patients With Lung Cancer and Smaller Tumor Size Elizabeth David, MD, Peter F. Thall, PhD,

Yang Wang, MD, PhD, Lynette L

A Phase II Study of Carboplatin, Etoposide, and Exisulind in Patients with Extensive Small Cell Lung Cancer: CALGB 30104 Ramaswamy Govindan, MD, Xiaofei.

David P. Mason, MD, Chase R. Brown, BS, Sudish C

Predictive Risk Factors for Patients With Cirrhosis Undergoing Heart Surgery Rawa Arif, MD, Philipp Seppelt, cand med, Simon Schwill, cand med, Dubravka.

Insertion of a left ventricular assist device in patients without thorough transplant evaluations: a worthwhile risk? Mathew Williams, MD, Jennifer Casher,

Jeffrey H. Shuhaiber, MD, Jeff Moore, MS, David B. Dyke, MD

Creating functional autogenous vascular access in older patients

Volume 64, Issue 4, Pages (October 2003)

Reliability of risk algorithms in predicting early and late operative outcomes in high-risk patients undergoing aortic valve replacement Todd M. Dewey,

External model validation of binary clinical risk prediction models in cardiovascular and thoracic surgery Graeme L. Hickey, PhD, Eugene H. Blackstone,

A Phase I Evaluation of Oral CI-1033 in Combination with Paclitaxel and Carboplatin as First-Line Chemotherapy in Patients with Advanced Non-small Cell.

Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease Joseph P. Archie, PhD, MD Journal of Vascular.

Risk factors for primary graft dysfunction after lung transplantation

Presentation transcript:

Incremental and independent value of cardiopulmonary exercise test measures and the Seattle Heart Failure Model for prediction of risk in patients with heart failure Todd Dardas, MD, MS, Yanhong Li, MD, MS, Shelby D. Reed, PhD, Christopher M. O’Connor, MD, David J. Whellan, MD, Stephen J. Ellis, PhD, Kevin A. Schulman, MD, William E. Kraus, MD, Daniel E. Forman, MD, Wayne C. Levy, MD The Journal of Heart and Lung Transplantation Volume 34, Issue 8, Pages 1017-1023 (August 2015) DOI: 10.1016/j.healun.2015.03.017 Copyright © 2015 International Society for Heart and Lung Transplantation Terms and Conditions

Figure 1 Predicted Seattle Heart Failure Model vs observed Kaplan-Meier survival plotted by quintiles of Seattle Heart Failure Model survival at (Top) 1-year and (Bottom) 3 years. The Journal of Heart and Lung Transplantation 2015 34, 1017-1023DOI: (10.1016/j.healun.2015.03.017) Copyright © 2015 International Society for Heart and Lung Transplantation Terms and Conditions

Figure 2 Area under the receiver operator characteristic (ROC) curves (Harrell’s C) for the Seattle Heart Failure Model (SHFM) survival over 1 year of follow-up (Top) with the addition of individual cardiopulmonary exercise testing (CPET) variables and (Bottom) with the addition of the 6-minute walk distance (6MWD) and multivariable models. CPXDUR, cardiopulmonary exercise duration; Ve/Vo2, expired volume per unit time/volume of carbon dioxide slope. The Journal of Heart and Lung Transplantation 2015 34, 1017-1023DOI: (10.1016/j.healun.2015.03.017) Copyright © 2015 International Society for Heart and Lung Transplantation Terms and Conditions